cognitive cybersecurity intelligence

News and Analysis

Search

UPMC Enteprises’ Biopharma Lead: We are At a Tipping Point When it Comes to China

UPMC Enteprises’ Biopharma Lead: We are At a Tipping Point When it Comes to China

Matthias Kleinz, executive vice president and head of translational sciences investments at UPMC Enterprises, explained why biopharma companies cannot ignore China anymore.
The post UPMC Enteprises’ Biopharma Lead: We are At a Tipping Point When it Comes to China appeared first on MedCity News.

Source: medcitynews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts